Carcinoma of the Skin Recruiting Phase 0 Trials for Nivolumab (DB09035)

Also known as: Skin Carcinoma / Cancer of skin (excl melanoma) / Carcinoma skin / Skin carcinoma NOS / Other and unspecified malignant neoplasm of skin, unspecified / [X]Malignant neoplasm of skin, unspecified (disorder) / Skin malignant neoplasm NOS / Malignant skin neoplasm NOS / Malignant neoplasm of skin NOS (disorder) / Malignant neoplasm of skin (disorder) / Primary malignant neoplasm of skin (disorder) / Skin neoplasms malignant and unspecified / Skin cancer / Malignant tumour of skin / Cancer of skin / Skin neoplasm malignant NOS / Skin neoplasm malignant

IndicationStatusPhase
DBCOND0152405 (Carcinoma of the Skin)Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03543969Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant MelanomaTreatment